Gline laid out a catalyst-rich 2026, stating, "The Phase IIb data for mostly is expected firmly in the second half of this year. We now know that because the study is fully enrolled, obviously. Same ...

Anthropic's quiet move to secure massive computing capacity marks a strategic escalation that could reshape competition among leading AI labs, intensifying pressure on rivals such as OpenAI and ...

The word “slop” and its meaning have made a major transition since it first appeared in the 1700s as a definition of soft mud. Now, "slop" is defined by the publisher Merriam-Webster to describe ...

Earlier this year, Phoenix New Times reported that MAGA-aligned Pinal County Attorney Brad Miller had hidden official communications by using the encrypted messaging app Signal, including at one point ...

Drosophila mojavensis, and propose that sleep at one stage of an animal's life might anticipate needs at a future stage. The results fit well with this model, but are correlative in nature. The work ...

NEW YORK, NY / ACCESS Newswire / February 6, 2026 / Capital becomes meaningful only when it alters how a company behaves. Until then, it’s just potential, visible but inactive. What matters is whether ...

President Donald Trump acknowledged Wednesday immigration enforcement could use a “softer touch” after federal agents killed two people in Minneapolis last month—a significant shift in tone as Trump ...

They’re searching for Nancy Guthrie’s heartbeat. Cops are flying over the Tucson desert with a high-tech Bluetooth signal detector, also known as a signal sniffer, in an attempt to locate a signal ...

Check Point Software Technologies Ltd. has acquired three venture-backed startups to enhance its cybersecurity capabilities. The company announced the deals, which are reportedly worth $150 million, ...

Databricks Inc. today announced that it has raised more than $7 billion in equity and debt financing to accelerate its growth efforts. The company first disclosed the investment late last year when it ...

CEO Matthew Gline opened the call highlighting "positive Phase II results for brepocitinib and cutaneous sarcoidosis and Roivant's financial results for the third quarter ended December 31, 2025." He ...